Continue to site >
Trending ETFs


Colgate-Palmolive Beats Q4 EPS Estimates (CL)

Before the opening bell on Thursday, Colgate-Palmolive (CL ) reported its fourth quarter financial results, posting higher profits than last year.

CL's Earnings in Brief

  • CL reported earnings of $628 million, or 68 cents per share, up from $564 million, or 60 cents per share, in the same quarter last year.
  • Excluding special items, earnings were $699 million, or 76 cents per share – above analysts’ view of 74 cents per share.
  • Revenue dropped to $4.22 billion from $4.36 billion last year. Analysts expected to see sales of $4.23 billion.

CEO Commentary

CL’s CEO Ian Cook noted: "As we enter 2015, macroeconomic conditions and foreign exchange volatility remain challenging. Despite that, we anticipate another year of solid organic sales growth driven by a full new product pipeline across all categories and geographies. While our long term goal of double-digit annual earnings per share growth remains unchanged, we continue to see significant deterioration in foreign exchange rates. As a result, we are planning for a year of gross margin expansion and low-single-digit earnings per share growth on a dollar basis, based on current spot rates and excluding charges related to the 2012 Restructuring Program. This earnings per share growth would reflect a double-digit increase on a currency neutral basis.”

CL's Dividend

The company will pay its next 36 cent dividend on February 16. The stock went ex-dividend on January 21. We expect the company to declare its next dividend in March.

Stock Performance

Shares of CL were up $1.91, or 2.93%, during pre-market trading Thursday.

CL Dividend Snapshot

As of market close on January 28, 2015

CL dividend yield annual payout payout ratio dividend growth

Click here to see the complete history of CL dividends.

The Bottom Line

Colgate-Palmolive (CL ) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.